Survodutide (BI 456906) research guide: dual GLP-1/glucagon receptor agonism, obesity and MASH research, SYNCHRONIZE Phase 3. Research use only.
Survodutide Research Guide: A Dual GLP-1/Glucagon Receptor Agonist Read More »
Retatrutide Phase 3 TRIUMPH-1 explained: 2026 topline data (up to ~28% weight loss), trial design, mechanism, and class comparison. Research use only.
Retatrutide Phase 3 TRIUMPH-1: The 2026 Obesity Data Explained Read More »
A research-grade component-level comparison of three tissue-repair peptide blends — the BPC-157/TB-500 repair core, GLOW with added GHK-Cu, and KLOW with added KPV — synthesized strictly from per-component preclinical literature.
KLOW vs GLOW vs BPC-157/TB-500 Blend: Component-Level Research Comparison Read More »
Mazdutide (LY3305677/IBI362) research guide: GLP-1/glucagon dual agonism, GLORY-1 and DREAMS trials, China NMPA approval. Research use only.
Mazdutide Research Guide: A Dual GLP-1/Glucagon Oxyntomodulin Analog Read More »
Cagrilintide & CagriSema research guide: amylin analog mechanism, REDEFINE Phase 3, amylin + GLP-1 co-administration. Research use only.
Cagrilintide and CagriSema Research Guide: Amylin Analog and GLP-1 Co-Administration Read More »
A source-ranked explainer of the conflicting identities used under the Adamax name, the direct-evidence gap, and the limits of Semax comparisons.
Adamax Explained: Naming, Identity Claims, and Evidence Gaps Read More »
A research-grade guide to FOXO4-DRI, the senolytic D-retro-inverso peptide that disrupts the FOXO4-p53 interaction to drive p53 nuclear exclusion and apoptosis selectively in senescent cells in preclinical models.
FOXO4-DRI Research Guide: Senolytic Peptide and the FOXO4-p53 Axis Read More »
A research-grade guide to PEG-MGF, the PEGylated C-terminal E-domain peptide of Mechano Growth Factor (the IGF-1Ec splice variant), and the contested preclinical literature behind it.
PEG-MGF Research Guide: Mechano Growth Factor and the IGF-1 Splice Variant Read More »
A research-grade guide to LL-37, the only human cathelicidin antimicrobial peptide, studied in vitro for membrane-permeabilizing antimicrobial action and receptor-mediated immunomodulation.
LL-37 Research Guide: Cathelicidin Antimicrobial Peptide Mechanisms Read More »
A research-grade comparison of GHRP-2, GHRP-6, and Hexarelin — three synthetic hexapeptide ghrelin-receptor (GHSR-1a) agonists — across sequence, potency, appetite signaling, cross-axis hormones, and Hexarelin\’s CD36 cardiac mechanism.
GHRP-2 vs GHRP-6 vs Hexarelin: Growth Hormone Secretagogue Comparison Read More »
A research-grade profile of triptorelin, the D-Trp6 GnRH superagonist whose continuous receptor occupancy suppresses gonadotropins after an initial flare, with mechanism, depot pharmacokinetics, and HPG-axis applications.
Triptorelin: The GnRH Superagonist Research Guide Read More »
A research-grade overview of IGF-1 LR3: its 83-residue Long-R3 architecture, IGF-1R signaling, the IGFBP-binding design rationale, and how it differs from native IGF-1.
IGF-1 LR3 Research Guide: Structure, Mechanism & IGFBP Design Read More »
A research-grade guide to MOTS-c, the 16-amino-acid mitochondrial-derived peptide from the USC Cohen lab studied for AMPK activation and exercise-mimetic metabolic signaling in preclinical models.
MOTS-c Research Guide: A Mitochondrial-Derived Peptide Read More »
A research-grade profile of tesamorelin, the stabilized GHRH(1-44) analog: trans-3-hexenoyl modification, GHRH-receptor mechanism, pharmacokinetics, and how it differs from sermorelin.
Tesamorelin Research Guide: Stabilized GHRH(1-44) Analog Read More »
A research-grade guide to KPV (Lys-Pro-Val), the C-terminal tripeptide of alpha-MSH studied for NF-kB-modulating anti-inflammatory signaling in intestinal and epithelial preclinical models.
KPV Peptide Research Guide: The C-Terminal Alpha-MSH Tripeptide Read More »
A research-grade overview of next-generation GLP-1 peptides: survodutide, mazdutide, cagrilintide, and CagriSema, their multi-receptor mechanisms, trial data, and mixed global regulatory status.
Next-Generation GLP-1 Research Peptides Explained Read More »
A research-grade guide to SLU-PP-332, a small-molecule pan-ERR agonist from the Burris laboratory studied as an exercise mimetic for mitochondrial-biogenesis and fatty-acid-oxidation signaling in preclinical models.
SLU-PP-332 Research Guide: A Pan-ERR Agonist Read More »
A research-grade guide to 5-Amino-1MQ, the small-molecule NNMT inhibitor studied in preclinical metabolic models for its effect on the NAD+ precursor and methyl-donor pools.
5-Amino-1MQ Research Guide: NNMT Inhibition & NAD+ Read More »
A research-grade guide to SS-31 (elamipretide), the mitochondria-targeted Szeto-Schiller tetrapeptide that binds cardiolipin, studied in preclinical bioenergetics and aging models.
SS-31 (Elamipretide) Research Guide: A Cardiolipin Peptide Read More »
A research-grade profile of liraglutide and dulaglutide: two foundational GLP-1 receptor agonists that solved the same short-half-life problem with fatty-acid acylation versus Fc-fusion.
Liraglutide and Dulaglutide Research Guide Read More »
A research-grade overview of thymosin alpha-1, the 28-amino-acid thymic immunomodulatory peptide: Goldstein-lineage discovery, Toll-like-receptor mechanism, antiviral and sepsis research, and reagent verification.
Thymosin Alpha-1: Research-Grade Peptide Guide Read More »
Sermorelin Research Guide: GHRH 1-29 Mechanism, Geref® FDA History & Research Applications Quick Answer Sermorelin is a synthetic 29-amino-acid peptide, the minimal receptor-active N-terminal fragment (GHRH 1-29) of the parent 44-residue human growth hormone-releasing hormone characterized at the Salk Institute in 1982. It acts as a selective agonist of the GHRH receptor (GHRHR) on anterior
Sermorelin Research Guide Read More »
Semaglutide is a 31-residue acylated GLP-1 receptor agonist studied for its effects on glucose regulation, body composition, and cardiovascular outcomes. Its long-chain fatty-acid albumin-binding tether extends plasma half-life to roughly seven days, enabling once-weekly dosing in research and clinical contexts. Trial evidence comes from the SUSTAIN, STEP, PIONEER, and SELECT programs — one of the
Semaglutide Research Guide Read More »
Compound guide to NAD+ as a coenzyme and sirtuin-pathway substrate, covering the yeast-aging Guarente lineage, modern SIRT1-7 mechanism, age-related decline, and replenishment-research strategies.
NAD+ Research Guide: Coenzyme & Sirtuin Pathway Read More »
Compound guide to PT-141 (Bremelanotide) as an MC4R-selective melanocortin agonist, covering the Hadley/Dorr Arizona lineage, central pharmacology, and the Vyleesi research-grade distinction.
PT-141 (Bremelanotide): MC4R Research Applications Read More »
Four-family taxonomic reference to specialty research peptides — eleven Apex catalog compounds spanning HPG-axis, melanocortin, neuropeptide, and investigational mechanism traditions.
Specialty Research Peptides: Apex Pillar Guide Read More »
Binary GHRH analog comparison of Tesamorelin (stabilized GHRH(1-44); FDA-approved Egrifta) and Sermorelin (GHRH(1-29)NH2 fragment; previously-approved Geref) — a dual-registrational-pedigree pair.
Tesamorelin vs Sermorelin: Comparing GHRH Analogs Read More »
Mechanism-distinct comparison of BPC-157 (15-residue Sikiric pentadecapeptide) and GHK-Cu (3-residue Pickart copper tripeptide) — protein-derived multi-pathway signaling versus copper-coordinated ECM remodeling.
BPC-157 vs GHK-Cu: Tissue Repair Peptide Comparison Read More »
Three single-agonist GLP-1 receptor agonists compared at research register: Liraglutide (Victoza, Saxenda), Semaglutide (Ozempic, Wegovy, Rybelsus), and Dulaglutide (Trulicity), across asymmetric Phase 3 evidence bases.
GLP-1 Agonists: Liraglutide vs Semaglutide vs Dulaglutide Read More »
Five-family taxonomic reference to longevity research peptides — Epithalon, Humanin, MOTS-c, NAD+, FOXO4-DRI, SS-31, and the full eight-compound Apex catalog with research-context regulatory framing.
Longevity & Bioregulator Research Peptides: Complete Guide Read More »
How mass spectrometry confirms peptide identity through ionization, m/z analysis, and tandem MS/MS sequencing — ESI vs MALDI, analyzer classes, and pairing with HPLC for >=99% verification.
Mass Spectrometry for Peptide Verification: A Guide Read More »
Receptor-pathway comparison of Ipamorelin (selective GHS-R1a pentapeptide) and CJC-1295 (tetra-substituted GHRH(1-29) analog) covering supra-additive synergy and the canonical combination research preparation.
Ipamorelin vs CJC-1295: GHS vs GHRH Receptor Compared Read More »
Vendor-agnostic researcher’s checklist for evaluating peptide suppliers across four functionally distinct vendor categories: purity, COA discipline, sequence identity, manufacturing standards, and red-flag signals.
How to Evaluate a Peptide Vendor: Researcher’s Checklist Read More »
Research-grade vs pharmaceutical-grade peptides explained: regulatory framework not quality hierarchy, cGMP vs ISO 17025, same-molecule worked examples, and verification overlap.
Research-Grade vs Pharmaceutical-Grade Peptides Explained Read More »
Why >=99% peptide purity matters: historical evolution of HPLC + MS standards, the impurity-inventory inside the trailing 1%, and why reproducibility breaks below the threshold.
Why >=99% Purity Matters in Research Peptides Read More »
Cascade-anchored reference to GH-axis research peptides — Sermorelin, Tesamorelin, CJC-1295, Ipamorelin, and the full fourteen-compound catalog — across five mechanism families with research-context regulatory framing.
Growth Hormone Peptides: GHRH Analogs & Secretagogues Read More »
Binary head-to-head of Retatrutide (triple GIP/GLP-1/glucagon agonist; research-only) and Tirzepatide (dual GIP/GLP-1 agonist; FDA-approved as Mounjaro and Zepbound) — across an approval-status divide.
Retatrutide vs Tirzepatide: Triple vs Dual Agonist Read More »
Compound guide to Tirzepatide as the first dual GIP/GLP-1 receptor agonist, covering modified-GIP backbone pharmacology, biased GLP-1R agonism, and the SURPASS and SURMOUNT trial programs.
Tirzepatide Research Guide: Dual GIP/GLP-1 Mechanism Read More »
Mechanism-family reference to GLP-1 metabolic research peptides — Semaglutide, Tirzepatide, Retatrutide, Liraglutide, Cagrilintide, Mazdutide, AOD9604, and beyond — across six receptor-agonism families.
GLP-1 / Metabolic Research Peptides: Complete Pillar Guide Read More »
Mechanism-family reference to tissue repair research peptides — BPC-157, TB-500, GHK-Cu, KPV, LL-37, Thymosin Alpha-1, ARA-290, and SS-31 — across six families.
Tissue Repair Research Peptides: Complete Pillar Guide Read More »
Side-by-side research comparison of BPC-157 and TB-500 — mechanism scales, structural differences, half-life, and combination research context with verified PubMed citations.
BPC-157 vs TB-500: Mechanism & Research Comparison Read More »
Cerebrolysin research guide covering the porcine-brain peptide-and-amino-acid mixture’s neurotrophic-factor-like mechanism, published clinical trial data, and pharmacokinetic profile from decades of research.
Cerebrolysin Research Guide: Neurotrophic Peptide Mixture Read More »
A mechanism-organized reference to nootropic and CNS research peptides — Cerebrolysin, Selank, Semax, Dihexa, DSIP, Humanin, PE-22-28, and Pinealon — across seven receptor families.
Nootropic & CNS Research Peptides: A Comprehensive Pillar Guide Read More »
Detailed comparison of Sermorelin vs CJC-1295 (Mod GRF 1-29) for GH-axis research. Molecular differences, DPP-4 resistance, half-life profiles, published pharmacokinetic data, combination protocols with Ipamorelin, and Tesamorelin comparison.
Sermorelin vs CJC-1295: Which GHRH Analog for Your Research? Read More »
Comprehensive dual research guide to Selank (tuftsin analog) and Semax (ACTH 4-10 analog) — two regulatory peptides from Russia’s Institute of Molecular Genetics. Mechanisms, BDNF modulation, anxiolytic vs nootropic profiles, published neuroscience data, and head-to-head comparison.
Selank & Semax: Nootropic Peptides from Russian Neuroscience Research Read More »
Comprehensive research guide to GHK-Cu (copper tripeptide-1). CAS 49557-75-7, MW 403.93 g/mol. Copper-dependent signaling mechanism, collagen/glycosaminoglycan synthesis, MMP regulation, published dermatological and tissue remodeling studies.
GHK-Cu Copper Peptide: Mechanism, Skin Research & Tissue Remodeling Read More »
Comprehensive research guide to Epithalon (Epitalon), the tetrapeptide telomerase activator from the Khavinson bioregulator peptide program. CAS 307297-39-8, MW 390.35 g/mol. Telomerase mechanism, pineal gland regulation, published longevity studies, and connection to the broader Khavinson peptide family.
Epithalon (Epitalon): Telomerase Research & the Khavinson Peptides Read More »
Comprehensive research guide to Melanotan II (MT-II). CAS 121062-08-6, MW 1024.18 g/mol. Non-selective melanocortin receptor agonist, MC1R/MC3R/MC4R/MC5R pharmacology, melanogenesis mechanism, published studies, comparison to Melanotan I and PT-141.
Melanotan II Research Guide: Melanocortin Receptor Pharmacology & Published Studies Read More »
Comprehensive research guide to AOD9604, the modified human growth hormone fragment 176-191. CAS 221231-10-3, MW 1815.08 g/mol. Lipolytic mechanism without IGF-1 stimulation, published metabolic data, comparison to full-length hGH and HGH Fragment 176-191, and research protocols.
AOD9604 Research Guide: The hGH Fragment for Metabolic Research Read More »
Complete CJC-1295 research guide explaining the critical difference between CJC-1295 with DAC and CJC-1295 without DAC (Mod GRF 1-29). GHRH receptor mechanism, pulsatile vs sustained GH release patterns, combination research with Ipamorelin, and published pharmacokinetic data.
CJC-1295 Research Guide: With DAC vs Without DAC Explained Read More »
Comprehensive research guide to Ipamorelin, the selective growth hormone secretagogue. CAS 170851-70-4, MW 711.85 g/mol. GHSR-1a selectivity mechanism, published pharmacology, combination research with CJC-1295, and comparison to GHRP-2 and GHRP-6.
Ipamorelin Research Guide: The Selective Growth Hormone Secretagogue Read More »
Comprehensive guide to Retatrutide (LY3437943), the first-in-class GIP/GLP-1/glucagon triple receptor agonist. CAS 2381089-83-2, MW 4471.5 g/mol. Triple agonist mechanism, Phase 2 NEJM data, comparison to Tirzepatide and Semaglutide, and research significance.
Comprehensive research guide to TB-500 (Thymosin Beta-4 fragment). CAS 77591-33-4, MW 4963.50 g/mol. Actin-binding mechanism, published studies in tissue remodeling and angiogenesis, storage protocols, and detailed comparison to BPC-157.
TB-500 (Thymosin Beta-4): Mechanism, Research Applications & Published Studies Read More »
Checked laboratory formulas for concentration, aliquot volume, unit conversion, U-100 label and graduation limits, and calculation error control.
Peptide Concentration and Volume Calculation Guide Read More »
A method-focused guide to peptide HPLC chromatograms, area percentages, integration decisions, system suitability, and orthogonal mass evidence.
HPLC Testing for Peptide Purity: How to Read Results and Their Limits Read More »
A source-scoped guide to bacteriostatic water composition, storage labels, solvent differences, and research-protocol decisions.
What Is Bacteriostatic Water? Composition, Storage, and Sterile Water Comparison Read More »
Learn how to read and evaluate a Certificate of Analysis (COA) for research peptides. Understand HPLC chromatograms, Mass Spectrometry data, purity percentages, red flags, and what separates a trustworthy COA from a fabricated one.
How to Read a Certificate of Analysis (COA) for Research Peptides Read More »
Complete guide to storing research peptides for maximum stability and shelf life. Covers lyophilized storage at -20°C, reconstituted refrigeration protocols, aliquoting strategies, degradation prevention, and compound-specific storage recommendations.
Peptide Storage Guide: Temperature, Stability & Shelf Life Explained Read More »
Side-by-side comparison of Semaglutide (GLP-1 agonist) and Tirzepatide (dual GIP/GLP-1 agonist) for researchers. Molecular structures, receptor pharmacology, head-to-head SURPASS-2 trial data, and the evolution toward triple-agonist peptides like Retatrutide.
Semaglutide vs Tirzepatide: Mechanism, Research Data & Key Differences Read More »
An evidence-scoped BPC-157 research guide covering chemical identity, model-specific mechanisms, preclinical findings, human evidence limits, and analytical verification.
BPC-157 Research Guide: Identity, Mechanisms, Evidence, and Limits Read More »
Research-only steps for verifying a lyophilized peptide, selecting a compatible solvent, calculating stock concentration, and documenting the result.
How to Reconstitute Peptides for Laboratory Research Read More »
Same day shipping
Multiple payment options
Real-time order tracking
We’re here to help
Apex Laboratory is a specialized supplier of high-purity chemical reagents and peptides. All products listed are strictly for in-vitro laboratory research and development use only.
